SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-023289
Filing Date
2024-06-10
Accepted
2024-06-10 09:00:30
Documents
41
Period of Report
2024-06-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42046
2 ex99-1.htm EX-99.1 20723
3 ex99-2.htm EX-99.2 26008
4 form8-k_001.jpg GRAPHIC 5681
5 ex99-1_001.jpg GRAPHIC 538006
6 ex99-1_002.jpg GRAPHIC 668879
7 ex99-1_003.jpg GRAPHIC 464615
8 ex99-1_004.jpg GRAPHIC 386314
9 ex99-1_005.jpg GRAPHIC 454943
10 ex99-1_006.jpg GRAPHIC 223042
11 ex99-1_007.jpg GRAPHIC 385627
12 ex99-1_008.jpg GRAPHIC 381639
13 ex99-1_009.jpg GRAPHIC 378195
14 ex99-1_010.jpg GRAPHIC 382703
15 ex99-1_011.jpg GRAPHIC 456282
16 ex99-1_012.jpg GRAPHIC 396975
17 ex99-1_013.jpg GRAPHIC 363557
18 ex99-1_014.jpg GRAPHIC 260624
19 ex99-1_015.jpg GRAPHIC 344404
20 ex99-1_016.jpg GRAPHIC 322517
21 ex99-1_017.jpg GRAPHIC 439088
22 ex99-1_018.jpg GRAPHIC 393737
23 ex99-1_019.jpg GRAPHIC 415896
24 ex99-1_020.jpg GRAPHIC 407638
25 ex99-1_021.jpg GRAPHIC 374012
26 ex99-1_022.jpg GRAPHIC 453674
27 ex99-1_023.jpg GRAPHIC 444496
28 ex99-1_024.jpg GRAPHIC 236914
29 ex99-2_001.jpg GRAPHIC 17221
  Complete submission text file 0001493152-24-023289.txt   13496978

Data Files

Seq Description Document Type Size
30 XBRL SCHEMA FILE lpcn-20240608.xsd EX-101.SCH 3015
31 XBRL LABEL FILE lpcn-20240608_lab.xml EX-101.LAB 34240
32 XBRL PRESENTATION FILE lpcn-20240608_pre.xml EX-101.PRE 22359
44 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 241031569
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)